Literature DB >> 20409859

A specific training on hypertension guidelines improves blood pressure control by more than 10% in hypertensive patients: the VALNORM study.

Roland Asmar1, Assya Achouba, Patrick Brunel, Ramzi El Feghali, Thierry Denolle, Bernard Vaisse.   

Abstract

VALNORM was designed to assess the impact on blood pressure (BP) control of a specific training in new European Society of Hypertension-International Society of Hypertension (ESH-ISH) guidelines for hypertension management. It was an 8-week prospective, randomized, open, blinded end points design study. General practitioners (GPs) located in France were randomized in two groups: group 1 (G1) without training to the guidelines and free attitude for the prescription whereas group 2 (G2) received a specific training in ESH guidelines. The primary efficacy criteria was strict BP control at week 8 (systolic BP/diastolic BP [SBP/DBP] <140/90 mm Hg and/or SBP/DBP <130/80 mm Hg if diabetes or renal insufficiency). All physicians used the same treatment (valsartan 80 or 160 mg once daily alone or in fixed combination with hydrochlorothiazide 12.5 or 25 mg once daily). BP was measured in the GPs' office with an electronic device. The groups GPs included 4,436 patients with essential uncontrolled hypertension (G1: 595 physicians, 2,308 patients; G2: 502 physicians, 2,128 patients). Patients' main characteristics were: age = 61 +/- 13 years, 52% female, BP = 160 +/- 13/92 +/- 9 mm Hg. No difference was observed between the two groups. The primary efficacy criteria showed in G2: 47.8% of BP control vs. G1: 44.7%, P = .005. Subgroup analysis according to age, body mass index (BMI), previous diabetes, and antihypertensive treatment showed that higher efficacy in G2 was more significant in these high-risk subgroups: age >60 years (G1: n = 1,150, G2: n = 1,035), BMI >/=25 kg/m(2) (G1: n = 1540, G2: n = 1430), diabetes (G1: n = 267, G2: n = 290), no previous antihypertensive treatment (G1: n = 1,111, G2: n = 1,005). The percentage of patients with controlled BP in each subgroup was: diabetes: G1 11.2% vs. G2 17.9% (P = .001), age >60 years: G1 40.3% vs. G2 43.7% (P = .022), BMI >/=25 kg/m(2): G1 43.2% vs. G2 45% (P = .165), untreated: G1 48.2% vs. G2 52.4% (P = .005). Specific training on the guidelines showed a positive impact on BP control, highly significant in patients at high cardiovascular risk such as diabetic hypertensive patients.

Entities:  

Year:  2007        PMID: 20409859     DOI: 10.1016/j.jash.2007.04.005

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN: 1878-7436


  6 in total

1.  Trends in Antihypertensive Medicine Utilization in the Republic of Srpska, Bosnia and Herzegovina: An Eleven-Year Follow-Up.

Authors:  Dragan Kalinić; Ranko Škrbić; Duško Vulić; Nataša Stojaković; Svjetlana Stoisavljević-Šatara; Miloš P Stojiljković; Vanda Marković-Peković; Ana Golić Jelić; Nataša Pilipović-Broćeta; Nathan D Wong; Brian Godman
Journal:  Front Pharmacol       Date:  2022-06-15       Impact factor: 5.988

2.  Are doctors assessing patients with hypertension appropriately at their initial presentation?

Authors:  Siew Lee Stalia Wong; Ping Yein Lee; Chirk Jenn Ng; Nik Sherina Hanafi; Yook Chin Chia; Pauline Siew Mei Lai; Su May Liew; Ee Ming Khoo
Journal:  Singapore Med J       Date:  2015-09       Impact factor: 1.858

Review 3.  Beneficial effects of nonpharmacological interventions in the management of essential hypertension.

Authors:  Anastasios Vamvakis; Eugenia Gkaliagkousi; Areti Triantafyllou; Eleni Gavriilaki; Stella Douma
Journal:  JRSM Cardiovasc Dis       Date:  2017-01-01

4.  Hypertension, knowledge, attitudes, and practices of primary care physicians in Ulaanbaatar, Mongolia.

Authors:  Maral Myanganbayar; Uurtsaikh Baatarsuren; Guanmin Chen; Roberta Bosurgi; Geoffrey So; Norm R C Campbell; Nasantogtokh Erdenebileg; Khulan Ganbaatar; Purevjargal Magsarjav; Manduukhai Batsukh; Tsatsralgerel Munkherdene; Tsolmon Unurjargal; Myagmartseren Dashtseren; Namkhaidorj Tserengombo; Batbold Batsukh; Andreas Bungert; Naranbaatar Dashdorj; Naranjargal Dashdorj
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-06-12       Impact factor: 3.738

5.  Doctors' Knowledge of Hypertension Guidelines Recommendations Reflected in Their Practice.

Authors:  Nafees Ahmad; Amer Hayat Khan; Irfanullah Khan; Amjad Khan; Muhammad Atif
Journal:  Int J Hypertens       Date:  2018-03-12       Impact factor: 2.420

6.  Impact of Intensive Lifestyle Treatment (Diet Plus Exercise) on Endothelial and Vascular Function, Arterial Stiffness and Blood Pressure in Stage 1 Hypertension: Results of the HINTreat Randomized Controlled Trial.

Authors:  Anastasios Vamvakis; Eugenia Gkaliagkousi; Antonios Lazaridis; Maria G Grammatikopoulou; Areti Triantafyllou; Barbara Nikolaidou; Nikolaos Koletsos; Panagiota Anyfanti; Christos Tzimos; Pantelis Zebekakis; Stella Douma
Journal:  Nutrients       Date:  2020-05-07       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.